(Q44899839)

7 December 2017

title

The effects of a 5-hydroxytryptamine 1A receptor gene polymorphism on the clinical response to fluvoxamine in depressed patients (English)

1 reference

7 December 2017

0 references

1 reference

Suzuki Y

1

1 reference

7 December 2017

Sawamura K

series ordinal

2

1 reference

7 December 2017

Someya T

series ordinal

3

1 reference

7 December 2017

language of work or name

1 reference

1 January 2004

1 reference

The Pharmacogenomics Journal

7 December 2017

published in

1 reference

7 December 2017

volume

4

1 reference

7 December 2017

issue

4

1 reference

7 December 2017

page(s)

283-286

1 reference

The clinical meaning of refractory depression: a review for the clinician

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500256

Current advances and trends in the treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500256

Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500256

Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500256

Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500256

Increase in extracellular serotonin produced by uptake inhibitors is enhanced after chronic treatment with fluoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500256

Augmentation of fluoxetine's antidepressant action by pindolol: analysis of clinical, pharmacokinetic, and methodologic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500256

Two naturally occurring amino acid substitutions in the human 5-HT1A receptor: glycine 22 to serine 22 and isoleucine 28 to valine 28.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500256

Novel mutations in the promoter and coding region of the human 5-HT1A receptor gene and association analysis in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500256

Lack of an association between 5-HT1A receptor gene structural polymorphisms and suicide victims

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500256

Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500256

Systematic screening for mutations in the promoter and the coding region of the 5-HT1A gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500256

Mood disorders in the general population represent an important and worldwide public health problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500256

7 January 2021

Health care reform for Americans with severe mental illnesses: report of the National Advisory Mental Health Council

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500256

7 January 2021

Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500256

7 January 2021

Effect of pindolol on onset of action of paroxetine in the treatment of major depression: intermediate analysis of a double-blind, placebo-controlled trial. Réseau de Recherche et d'Expérimentation Psychopharmacologique

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500256

7 January 2021

Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500256

7 January 2021

Identifiers

DOI

10.1038/SJ.TPJ.6500256

1 reference

7 December 2017

1 reference